Pharmacogenetic diversification by alternative translation initiation: background channels to the fore: Commentary on Kisselbach et al., Br J Pharmacol 171: 5182–5194

Pharmacogenetic diversification by alternative translation initiation: background channels to the fore: Commentary on Kisselbach et al., Br J Pharmacol 171: 5182–5194

Linked Article This article is a Commentary on Kisselbach J, Seyler C, Schweizer PA, Gerstberger R, Becker R, Katus HA and Thomas D (2014). Modulation of K2P2.1 and K2P10.1 K+ channel sensitivity to carvedilol by alternative mRNA translation initiation. Br J Pharmacol 171: 5182–5194. doi: 10.1111/bp...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology Vol. 172; no. 18; pp. 4591 - 4593
Main Author: Abbott, G W
Format: Journal Article
Language:English
Published: England John Wiley & Sons, Ltd 01-09-2015
Subjects:
Anti‐arrhythmic
cardiac arrhythmia
Commentaries
potassium channel
cardiac arrhythmia
potassium channel
Anti-arrhythmic
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Linked Article This article is a Commentary on Kisselbach J, Seyler C, Schweizer PA, Gerstberger R, Becker R, Katus HA and Thomas D (2014). Modulation of K2P2.1 and K2P10.1 K+ channel sensitivity to carvedilol by alternative mRNA translation initiation. Br J Pharmacol 171: 5182–5194. doi: 10.1111/bph.12596
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-1188
1476-5381
DOI:10.1111/bph.12630